Melphalan 2mg Tablet Franchise in Ahmedabad

Anticancer & Chemotherapy Drug Supplier in Mumbai

Melophit 2 Tablet Distributor in Delhi

Oncology Therapy Tablet Franchise Opportunity in Bangalore

Chemotherapy Medicine Stockist in Hyderabad
Melphalan 2mg Export & Manufacturing in Chandigarh

Home/Products /melphalan-2mg-tablet

Melophit 2 Tablet

Composition : Melphalan (2mg) Tablet

Dosage Form : Tablet

Packaging Type : in a Bottle

Packaging : 30 Tablets

Price : ₹0/-

Please Contact For Best Price

Melophit 2 Tablet contains Melphalan 2mg, a well-established alkylating agent used in oncology for the treatment of multiple myeloma and selected solid tumors such as ovarian cancer. It plays a key role in chemotherapy protocols aimed at controlling malignant cell proliferation and disease progression.

Melphalan works by cross-linking DNA strands in rapidly dividing cancer cells, thereby inhibiting DNA replication and inducing cell death. This cytotoxic action makes it effective in reducing tumor burden when used under strict medical supervision as part of combination or maintenance chemotherapy regimens.

For distributors and healthcare suppliers, Melophit 2 Tablet is a specialty oncology product, primarily utilized in cancer hospitals, oncology clinics, and tertiary care centers. The consistent requirement for oral chemotherapy agents in long-term cancer management ensures a stable and specialized demand.

Adding Melophit 2 Tablet to your oncology and anticancer therapy segment creates opportunities in hospital supply chains, specialty pharmacies, export markets, and third-party manufacturing. Its established clinical role, controlled usage, and importance in cancer treatment protocols make it a critical product within pharmaceutical oncology portfolios.

Read More

About the Product

Melophit 2 Tablet contains Melphalan 2mg, a well-established alkylating agent used in oncology for the treatment of multiple myeloma and selected solid tumors such as ovarian cancer. It plays a key role in chemotherapy protocols aimed at controlling malignant cell proliferation and disease progression.

Melphalan works by cross-linking DNA strands in rapidly dividing cancer cells, thereby inhibiting DNA replication and inducing cell death. This cytotoxic action makes it effective in reducing tumor burden when used under strict medical supervision as part of combination or maintenance chemotherapy regimens.

For distributors and healthcare suppliers, Melophit 2 Tablet is a specialty oncology product, primarily utilized in cancer hospitals, oncology clinics, and tertiary care centers. The consistent requirement for oral chemotherapy agents in long-term cancer management ensures a stable and specialized demand.

Adding Melophit 2 Tablet to your oncology and anticancer therapy segment creates opportunities in hospital supply chains, specialty pharmacies, export markets, and third-party manufacturing. Its established clinical role, controlled usage, and importance in cancer treatment protocols make it a critical product within pharmaceutical oncology portfolios.

Common side effects may include nausea, vomiting, loss of appetite, fatigue, and bone marrow suppression leading to anemia, leukopenia, or thrombocytopenia. Serious side effects may include increased risk of infections, bleeding, or secondary malignancies with long-term use.

Melophit 2 Tablet is indicated for the treatment of multiple myeloma, ovarian carcinoma, and other selected malignancies as determined by an oncologist. It may also be used in conditioning regimens prior to stem cell transplantation.

Melophit 2 Tablet should be taken strictly under the supervision of a qualified oncologist. Regular monitoring of blood counts is essential during therapy. Patients should inform their doctor about any infections, unusual bleeding, pregnancy, or breastfeeding before starting treatment.

Store Melophit 2 Tablet in a cool, dry place away from light and moisture. Keep out of reach of children. Do not use the tablet after the expiry date mentioned on the pack.

Get in Touch